IRONWOOD PHARMACEUTICALS INC Quarterly Interest Expense in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q1 2024.
  • Ironwood Pharmaceuticals Inc Interest Expense for the quarter ending March 31, 2024 was $7.23M, a 374% increase year-over-year.
  • Ironwood Pharmaceuticals Inc Interest Expense for the twelve months ending March 31, 2024 was $27.3M, a 303% increase year-over-year.
  • Ironwood Pharmaceuticals Inc annual Interest Expense for 2023 was $21.6M, a 185% increase from 2022.
  • Ironwood Pharmaceuticals Inc annual Interest Expense for 2022 was $7.6M, a 75.6% decline from 2021.
  • Ironwood Pharmaceuticals Inc annual Interest Expense for 2021 was $31.2M, a 5.67% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $27.3M $7.23M +$5.7M +374% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $21.6M $8.42M +$6.9M +452% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $14.7M $9.84M +$8.32M +546% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $6.42M $1.84M -$367K -16.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $6.78M $1.53M -$814K -34.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $7.6M $1.53M -$6.43M -80.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $14M $1.52M -$6.32M -80.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $20.3M $2.21M -$5.53M -71.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $25.9M $2.34M -$5.29M -69.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $31.2M $7.95M +$430K +5.72% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $30.7M $7.84M +$422K +5.69% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $30.3M $7.73M +$414K +5.66% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $29.9M $7.63M +$406K +5.62% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $29.5M $7.52M +$398K +5.59% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $29.1M $7.42M -$3.04M -29.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $32.1M $7.32M -$2.11M -22.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $34.2M $7.22M -$2.37M -24.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $36.6M $7.12M -$2.46M -25.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $39.1M $10.5M +$975K +10.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $38.1M $9.43M +$47K +0.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $38M $9.59M +$319K +3.44% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $37.7M $9.59M +$380K +4.13% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-17
Q3 2018 $37.3M $9.48M +$347K +3.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $37M $9.38M +$337K +3.73% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 $36.7M $9.27M +$290K +3.23% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $36.4M $9.21M -$448K -4.64% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-13
Q3 2017 $36.8M $9.14M -$630K -6.45% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $37.4M $9.05M -$781K -7.95% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $38.2M $8.98M -$924K -9.33% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $39.2M $9.65M -$327K -3.28% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-25
Q3 2016 $39.5M $9.77M -$256K -2.56% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $39.7M $9.83M +$3.95M +67.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $35.8M $9.91M +$4.69M +89.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $31.1M $9.98M +$4.72M +89.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-22
Q3 2015 $26.4M $10M +$4.7M +88.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $21.7M $5.87M +$571K +10.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $21.1M $5.22M -$63K -1.19% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $21.2M $5.26M -$38K -0.72% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-22
Q3 2014 $21.2M $5.32M +$55K +1.05% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $21.1M $5.3M -$15K -0.28% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $21.2M $5.28M +$162K +3.16% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $21M $5.3M +$5.28M +29333% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $15.7M $5.27M +$5.25M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $10.5M $5.32M +$5.31M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $5.17M $5.12M +$5.11M Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 $59K $18K +$4K +28.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-18
Q3 2012 $55K $14K* -$2K Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $57K $13K* -$4K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $61K $14K* -$2K Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-23
Q4 2011 $63K $14K Oct 1, 2011 Dec 31, 2011 10-K 2014-02-07
Q3 2011 $16K -$65K -80.2% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $17K -$27K -61.4% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $16K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 $81K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $44K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.